Gefitinib for advanced non010small cell lung cancer https://t.co/tGUiIXLeI1
Gefitinib for advanced non010small cell lung cancer https://t.co/tGUiIXLeI1
Gefitinib for advanced non‐small cell lung cancer https://t.co/tGUiIXLeI1
Gefitinib for advanced non‐small cell lung cancer https://t.co/tGUiIXLeI1
Gefitinib for advanced non010small cell lung cancer https://t.co/tGUiIXLeI1
非小細胞肺癌に対するゲフィチニブと無治療あるいは化学療法との比較 https://t.co/KCs5URxSOr
@pankratna Gefitnib prolongs survival in lung cancer with EGFR mutations, by some months atleast. 5 year survival (percenatge of patients who are alive at 5 years of follow-up) of around 15% Cochrane reviews are reliable for this purpose: https://t.co/gCj2
TPCH article contribution https://t.co/zCvGXE86hs
A comparison of #gefitinib with no therapy or chemotherapy for non-small cell lung cancer. Read the latest review: https://t.co/b66t664Y1A https://t.co/o5X31EMJQu
RT @gedefo_sefh: "A comparison of gefitinib with no therapy or chemotherapy for non-small cell lung cancer" https://t.co/225y48mskP
New Cochrane Review: Gefitinib for advanced non-small cell lung cancer https://t.co/H2kmn3Yzk0 #lungcancer
"A comparison of gefitinib with no therapy or chemotherapy for non-small cell lung cancer" https://t.co/225y48mskP
Do patients with non-small cell lung cancer live longer if they are given #gefitinib? Latest review of the evidence: https://t.co/gGm3mMRo84 #lungcancer https://t.co/VGl1WozR2o
Gefitinib for advanced non-small cell lung cancer @CochraneLibrary https://t.co/OaPrbh8uPx Shows that gefitinib, when compared with standard 1st/2nd-line chemotherapy or maintenance therapy, probably has a beneficial effect on progression-free survival &am
A comparison of gefitinib with no therapy or chemotherapy for non-small cell lung cancer https://t.co/RNP8gjmMXK